By Katie Thomas
The company says it will switch to a broader approach for its experimental drug, remdesivir. But it was overwhelmed by demand for a potential treatment promoted by President Trump.
Published: March 22, 2020 at 08:00PM
from NYT Health https://ift.tt/33M1MeD
via IFTTT
from WordPress https://ift.tt/399jMAI
via IFTTT
No comments:
Post a Comment